creatine with semaglutide Weight loss medications are groundbreaking tools in the fight against obesity and metabolic syndrome. Like any tool, they can be used responsibly or irresponsibly. We've been leveraging weight loss medications, like semaglutide, Weight loss medications are groundbreaking

Key changes every healthcare professional should know: Obesity is formally treated as a chronic, relapsing disease Lifestyle intervention remains essential, but anti-obesity medications are now considered a core component of care, not a last resort

The Veterans Affairs system covers Wegovy only under narrow conditions, leaving many veterans without access to GLP-1 therapy

Future clinical trials should aim to distinguish the direct analgesic effects of GLP-1RAs from their metabolic benefits and explore their broader applications in pain conditions

Results GLP-1R activation increased the CSF secretion rate with an associated elevation of the ICP, whereas inhibition of the receptor reduced the rate of CSF secretion